In summary, our findings highlight a novel type of glioneuronal tumor driven by different RTK fusions accompanied by recurrent alterations in ATRX and homozygous deletions of CDKN2A/B. The gene discussed is CDKN2A; the disease is mixed neuronal-glial tumor.